BioMarin Pharmaceutical Inc. Common Stock (BMRN)

Stock · NASDAQ · Health Care

$64.67as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$53.39

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

BMRN
BioMarin Pharmaceutical Inc. Common Stock
$64.67
▼ 0.95%
Market cap $11.60BP/E —
MDGL
Madrigal Pharmaceuticals Inc. Common Stock
$534.12
▼ 1.76%
Market cap $11.14BP/E —
$393.61$615
AXSM
Axsome Therapeutics Inc. Common Stock
$199.01
▼ 3.52%
Market cap $10.86BP/E —
$112.9$260.19
ABVX
Abivax SA American Depositary Shares
$113.41
▼ 0.78%
Market cap $10.74BP/E —
$60.45$139
SMMT
Summit Therapeutics Inc. Common Stock
$13.71
▼ 4.33%
Market cap $10.41BP/E —
$12.07$29.23
ELAN
Elanco Animal Health Incorporated Common Stock
$24.12
▼ 1.51%
Market cap $12.85BP/E —
$17.11$27.98
CYTK
Cytokinetics Incorporated Common Stock
$72.17
▼ 7.36%
Market cap $9.51BP/E —
$35.22$88.31

Symbol	Market cap	P/E ratio	Price	1D	52-week range
BMRN BioMarin Pharmaceutical Inc. Common Stock	$11.60B	—	$64.67	▼ 0.95%
MDGL Madrigal Pharmaceuticals Inc. Common Stock	$11.14B	—	$534.12	▼ 1.76%	$393.61$615
AXSM Axsome Therapeutics Inc. Common Stock	$10.86B	—	$199.01	▼ 3.52%	$112.9$260.19
ABVX Abivax SA American Depositary Shares	$10.74B	—	$113.41	▼ 0.78%	$60.45$139
SMMT Summit Therapeutics Inc. Common Stock	$10.41B	—	$13.71	▼ 4.33%	$12.07$29.23
ELAN Elanco Animal Health Incorporated Common Stock	$12.85B	—	$24.12	▼ 1.51%	$17.11$27.98
CYTK Cytokinetics Incorporated Common Stock	$9.51B	—	$72.17	▼ 7.36%	$35.22$88.31

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.